Literature DB >> 10656512

Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics.

T Langheinrich1, L Tebartz van Elst, W A Lagrèze, M Bach, C H Lücking, M W Greenlee.   

Abstract

OBJECTIVES: Visual contrast detection thresholds and suprathreshold contrast discrimination thresholds were compared to luminance and flash/pattern electroretinograms (ERG) and visually evoked potentials (VEP) in patients with Parkinson's disease (n = 31), patients with multiple system atrophy (n = 6), patients with progressive supranuclear palsy (n = 6) and control patients without central nervous disease (n = 33).
METHODS: The stimuli were luminance modulated full-field (flash) or horizontally oriented sinewave gratings (pattern), the latter having either a low (0.5 cycles/deg) or medium (4.0 cycles/deg) spatial frequency. Stimulus contrast ranged from 10 to 80% so that contrast response functions could be derived.
RESULTS: Contrast thresholds were higher in the patients with Parkinson's disease than in the control patients. Contrast discrimination thresholds were also somewhat elevated in patients with Parkinson's disease. Pattern ERG amplitudes were significantly reduced in patients with Parkinson's disease for the medium spatial frequency stimulus, but less for the low spatial frequency and flash stimuli.
CONCLUSIONS: Our results suggest that Parkinson's disease impairs contrast processing in the retina. VEP amplitudes did not significantly differ between the groups for the conditions tested. Patients with progressive supranuclear palsy also showed impaired contrast perception and reduced ERG amplitudes, whereas patients with multiple system atrophy were less impaired.

Entities:  

Mesh:

Year:  2000        PMID: 10656512     DOI: 10.1016/s1388-2457(99)00223-0

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  19 in total

1.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

2.  Retinal dysfunction of contrast processing in major depression also apparent in cortical activity.

Authors:  Emanuel Bubl; Elena Kern; Dieter Ebert; Andreas Riedel; Ludger Tebartz van Elst; Michael Bach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-08       Impact factor: 5.270

3.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

4.  Light- and dopamine-regulated receptive field plasticity in primate horizontal cells.

Authors:  Ai-Jun Zhang; Roy Jacoby; Samuel M Wu
Journal:  J Comp Neurol       Date:  2011-08-01       Impact factor: 3.215

5.  Visual information processing in recently abstaining methamphetamine-dependent individuals: evoked potentials study.

Authors:  Jan Kremlácek; Ladislav Hosák; Miroslav Kuba; Jan Libiger; Jirí Cízek
Journal:  Doc Ophthalmol       Date:  2008-06-19       Impact factor: 2.379

6.  Little effect of 0.01% atropine eye drops as used in myopia prevention on the pattern electroretinogram.

Authors:  Lisa-Marie Anders; Sven P Heinrich; Wolf A Lagrèze; Lutz Joachimsen
Journal:  Doc Ophthalmol       Date:  2019-01-24       Impact factor: 2.379

7.  A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA).

Authors:  Claire S Barnes; Jiong Yan; George R Wilmot
Journal:  Doc Ophthalmol       Date:  2008-11-21       Impact factor: 2.379

8.  Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.

Authors:  F Sartucci; G Orlandi; U Bonuccelli; D Borghetti; L Murri; C Orsini; L Domenici; V Porciatti
Journal:  Neurol Sci       Date:  2006-02       Impact factor: 3.307

9.  Retinal contrast transfer functions in adults with and without ADHD.

Authors:  Emanuel Bubl; Michael Dörr; Alexandra Philipsen; Dieter Ebert; Michael Bach; Ludger Tebartz van Elst
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

10.  Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease.

Authors:  Evangelia E Tsironi; Anna Dastiridou; Andreas Katsanos; Efthymios Dardiotis; Stella Veliki; Gianna Patramani; Fani Zacharaki; Stella Ralli; Georgios M Hadjigeorgiou
Journal:  BMC Ophthalmol       Date:  2012-10-02       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.